{"title":"一例无症状性体细胞腺瘤与妊娠","authors":"Sara Askaoui","doi":"10.19080/gjorm.2018.06.555687","DOIUrl":null,"url":null,"abstract":"Somatotropic adenomas are classically a source of hypersecretion of growth hormone (GH) and consequently of insulin growth factor 1 (IGF1) and responsible of the clinical signs of acromegaly. Rarely, these adenomas remain “silent”, without any obvious clinical manifestation. They can then be screened on the basis of a systematic assay of growth hormone under oral glucose tolerance test (GH/ OGTT) and IGF1 or can be diagnosed only in the immunohistochemical study as in the case of a patient we report and the evolution of her disease during pregnancy.","PeriodicalId":92369,"journal":{"name":"Global journal of reproductive medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Silent Somatotropic Adenoma and Pregnancy: About A Case\",\"authors\":\"Sara Askaoui\",\"doi\":\"10.19080/gjorm.2018.06.555687\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Somatotropic adenomas are classically a source of hypersecretion of growth hormone (GH) and consequently of insulin growth factor 1 (IGF1) and responsible of the clinical signs of acromegaly. Rarely, these adenomas remain “silent”, without any obvious clinical manifestation. They can then be screened on the basis of a systematic assay of growth hormone under oral glucose tolerance test (GH/ OGTT) and IGF1 or can be diagnosed only in the immunohistochemical study as in the case of a patient we report and the evolution of her disease during pregnancy.\",\"PeriodicalId\":92369,\"journal\":{\"name\":\"Global journal of reproductive medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global journal of reproductive medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19080/gjorm.2018.06.555687\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal of reproductive medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/gjorm.2018.06.555687","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Silent Somatotropic Adenoma and Pregnancy: About A Case
Somatotropic adenomas are classically a source of hypersecretion of growth hormone (GH) and consequently of insulin growth factor 1 (IGF1) and responsible of the clinical signs of acromegaly. Rarely, these adenomas remain “silent”, without any obvious clinical manifestation. They can then be screened on the basis of a systematic assay of growth hormone under oral glucose tolerance test (GH/ OGTT) and IGF1 or can be diagnosed only in the immunohistochemical study as in the case of a patient we report and the evolution of her disease during pregnancy.